logo

Moleculin Biotech Inc (MBRX)



Trade MBRX now with
  Date
  Headline
7/21/2020 7:36:08 AM Moleculin Biotech Says New Independent Laboratory Testing Confirms Antiviral Activity Of WP1122 Against Coronavirus
7/15/2020 7:34:24 AM Moleculin Biotech Enters Deal With Sterling Pharma USA LLC For US Production Of WP1122
7/2/2020 7:35:38 AM Moleculin Biotech Announces Update On Clinical Development Plan For Annamycin
6/25/2020 7:34:04 AM Moleculin Announces Preclinical Data Confirms Efficacy Of Annamycin In Lung Metastases
6/4/2020 7:40:35 AM Moleculin Biotech Submits Regulatory Requests To Open Two Addl Clinical Sites For Phase 1/2 Study Of Annamycin In Poland
5/18/2020 7:32:18 AM Moleculin Announces Nasdaq Trading Halt Pending Receipt Of Additional Information
5/11/2020 7:39:59 AM Moleculin Biotech Provides Additional Comments Regarding Trading Halt
5/8/2020 7:32:07 AM Moleculin To Adjourn 2020 Annual Meeting Of Stockholders To June 15, 2020
4/28/2020 7:38:51 AM Moleculin Biotech Now Authorized By URPL To Accelerate Phase 1 Dose Escalation Portion Of Clinical Trial Of Annamycin
4/28/2020 7:30:00 AM Moleculin Approved to Accelerate European Clinical Trial (Press Release)